Showing results (411-420 of 540) with videos related to
Sort By:
Pageof 54
Cell Metabolism|January 10, 2017
Adipocyte Dynamics and Reversible Metabolic Syndrome in Mice with an Inducible Adipocyte-Specific Deletion of the Insulin ReceptorMasaji Sakaguchi, Shiho Fujisaka, Weikang Cai, et al.Clinical Epigenetics|October 21, 2020
Leveraging locus-specific epigenetic heterogeneity to improve the performance of blood-based DNA methylation biomarkersBrendan F Miller, Thomas R Pisanic Ii, Gennady Margolin, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
A phase I dose-escalation study of ZD6474 in Japanese patients with solid, malignant tumorsTomohide Tamura, Hironobu Minami, Yasuhide Yamada, et al.Lung Cancer (Amsterdam, Netherlands)|April 16, 2024
Long-term follow-up and exploratory analysis of lenvatinib in patients with metastatic or recurrent thymic carcinoma: Results from the multicenter, phase 2 REMORA trialSeiji Niho, Jun Sato, Miyako Satouchi, et al.International Journal of Environmental Research and Public Health|December 18, 2020
Africans Who Arrive in the United States before 20 Years of Age Maintain Both Cardiometabolic Health and Cultural Identity: Insight from the Africans in America StudyElyssa M Shoup, Thomas Hormenu, Nana H Osei-Tutu, et al.International Journal of Environmental Research and Public Health|July 1, 2020
Stress Measured by Allostatic Load Varies by Reason for Immigration, Age at Immigration, and Number of Children: The Africans in America StudyThomas Hormenu, Elyssa M Shoup, Nana H Osei-Tutu, et al.Investigational New Drugs|August 12, 2015
A phase I/Ib study of trametinib (GSK1120212) alone and in combination with gemcitabine in Japanese patients with advanced solid tumorsAkiyoshi Kasuga, Kazuhiko Nakagawa, Fumio Nagashima, et al.The Oncologist|September 12, 2020
Phase I/II Study of Cisplatin plus Nab-Paclitaxel with Concurrent Thoracic Radiotherapy for Patients with Locally Advanced Non-Small Cell Lung CancerHidetoshi Hayashi, Masakazu Ogura, Takashi Niwa, et al.Japanese Journal of Clinical Oncology|February 24, 2018
Phase 3 study of ceritinib vs chemotherapy in ALK-rearranged NSCLC patients previously treated with chemotherapy and crizotinib (ASCEND-5): Japanese subsetKatsuyuki Kiura, Fumio Imamura, Hiroshi Kagamu, et al.Frontiers in Endocrinology|May 21, 2025
Energy landscape analysis of health checkup data clarified multiple pathways to diabetes development in obese and non-obese subjectsRyo Ito, Makito Oku, Iwao Kimura, et al.Pageof 54